Modi Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells
Cytospire Therapeutics develops multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s immune system. Its platform targets gamma delta T cells to generate anti tumour immune responses for patients with cancer and other diseases.
Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.
Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs
Ignota Labs applies AI-driven drug discovery to rescue and redevelop failed drug candidates, identifying and resolving safety issues so promising therapies can be revived and progressed back into clinical development.
- 2(12 months)
- modivc.com
- Update Information
More venture news
- 28 May 2026
GeordieGeordie raises a £22m Series A led by Balderton to help enterprises monitor and govern autonomous AI agents
Series ACybersecurity - 13 May 2026
HapplHappl raises £8m Series A led by Portage Ventures to build global employee benefits operating system for multinational employers
Series AHR - 12 May 2026
AdfinAdfin lands £13m Series A led by Index Ventures for agentic business payments and cash management platform
Series AFintech
